Stockscreener 앱 받기
0.4157
1.96%
-0.0083
시간 외 거래:
.42
0.0043
+1.03%
전일 마감가:
$0.424
열려 있는:
$0.4175
하루 거래량:
76,539
Relative Volume:
0.05
시가총액:
$6.57M
수익:
$1.84M
순이익/손실:
$-17.51M
주가수익비율:
-0.3002
EPS:
-1.3849
순현금흐름:
$-17.30M
1주 성능:
-16.69%
1개월 성능:
-24.35%
6개월 성능:
-50.97%
1년 성능:
-62.55%
1일 변동 폭
$0.4157
$0.4798
1주일 범위
$0.4157
$0.52
52주 변동 폭
$0.37
$1.50
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.4157 | 6.57M | 1.84M | -17.51M | -17.30M | -1.3849 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-08 | 개시 | ROTH Capital | Buy |
| 2021-07-29 | 개시 | Aegis Capital | Buy |
| 2020-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 개시 | Oppenheimer | Outperform |
Evogene Ltd 주식(EVGN)의 최신 뉴스
Evogene stock falls to USD 0.50 after board turmoil - ad-hoc-news.de
Evogene Faces Dissident Shareholder Tender Offer and Board Resignations After September AGM - tipranks.com
Two Evogene (EVGN) directors resign amid investor claims over AGM vote - Stock Titan
L.I.A. Pure Capital Intends to Commence a Special Tender Offer to Evogene - marketscreener.com
Evogene (NASDAQ: EVGN) Share Price, EVGN Stock News, EVGN Share Price & Updates - Kalkine
Investor group in Evogene (NASDAQ: EVGN) plans a special tender offer under Israeli law - Stock Titan
8.6% Evogene (EVGN) holder bought 1.26M shares in August - Stock Titan
Casterra announces $2.2 Mn of purchase orders to supply castor seeds - AgroSpectrum India
Evogene Confirms Board Slate at September 4 Shareholder Meeting - TipRanks
Evogene Ltd. Approves Board Appointments - marketscreener.com
Evogene (EVGN) sets seven-member board after 2026 shareholder vote - Stock Titan
Evogene stock trades lower as biotech investors eye latest pipeline moves - AD HOC NEWS
L.I.A. Pure Capital Acquires 19.35% Activist Stake in Evogene (NASDAQ: EVGN) - Kalkine Media
L.I.A. Pure Capital Takes 19.35% Activist Stake in Evogene (NASDAQ: EVGN), Pushes for Board Changes - kalkinemedia.com
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance Australia
Evogene urges shareholders to support current b... - pluang.com
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - TradingView
Evogene stock holds steady as investors eye latest genomics progress - ad-hoc-news.de
Evogene (EVGN) investor group pushes for board seats at annual meeting - Stock Titan
[6-K] Evogene Ltd. Current Report (Foreign Issuer) - Stock Titan
Evogene | 4: Statement of changes in beneficial ownership of securities-Officer Tarcic Gabi - Moomoo
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com India
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees - PR Newswire
Evogene Ltd (EVGN) Stock News Today - tradingkey.com
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionMoney Flow - dars.gov.et
Evogene Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Evogene | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Evogene earnings beat by $0.15, revenue topped estimates - Investing.com India
Evogene Q2 2026 Deep Dive: EPS Beats, Revenue Down 35% - AlphaStreet
Teleconferência de Resultados do 2T26 da Evogene (EVGN): Prejuízo Diminui com Expansão da ChemPass AI - TradingKey
Evogene Q2 2026: Loss Narrows 50.0% to -$0.14/Share, Revenue Down 35% - AlphaStreet
Earnings call transcript: Evogene narrows Q2 2026 loss as shares fall 7.8% - Investing.com Nigeria
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Global Agriculture
EVGN: Q2 net loss down 62% year-over-year as AI-driven focus delivers operational and financial gains - TradingView
EVGN: Q2 2026 net loss fell 62% year-over-year as AI-driven transformation boosted efficiency - TradingView
Evogene: Q2 Earnings Snapshot - theheraldreview.com
Evogene Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Evogene Q2 Results: EPS misses estimate, sales fall 61% YoY - scanx.trade
Evogene Q2 2026 Earnings: Net Loss Narrows Despite Lower Revenue - TradingKey
Evogene Reports Second Quarter and First Half 2026 Financial Results - PR Newswire
EVOGENE ($EVGN) Releases Q2 2026 Earnings - Moomoo
Evogene (EVGN) cuts staff to 38 as it overhauls into AI-driven chemistry - Stock Titan
Earnings To Watch: Evogene Ltd (EVGN) Q2 2026 -- GF Value Sees 15% Downside - Yahoo Finance
Freightos Names Yaron Eldad as Chief Financial Officer - marketscreener.com
EVGN Q2'26 Earnings: EPS estimate is (0.27) USD - TradingView
Armistice Capital (EVGN) discloses 4.99% beneficial stake in Evogene shares - Stock Titan
Evogene chairman to address dissident shareholder issues in Aug 18 earnings call - Pluang
Evogene Chairman Joins Company Results Call on August 18 - Stock Titan
Why Did EVGN Shares Drop More Than 14% Today? - Stocktwits
Evogene Ltd. (EVGN) investors lift beneficial stake to 19.35% of shares - Stock Titan
Evogene (EVGN): Director Leon Recanati buys 460,000 shares, now holds 8.6% - Stock Titan
Evogene Ltd (EVGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):